<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CXCL1 &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/cxcl1/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 10 Oct 2026 01:10:52 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>CXCL1 &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Immune Cells Feed Breast Cancer Tumors as AI and DNA Testing Reshape Cancer Care</title>
		<link>https://bioengineer.org/immune-cells-feed-breast-cancer-tumors-as-ai-and-dna-testing-reshape-cancer-care/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sat, 10 Oct 2026 01:10:52 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[biliary tract cancer]]></category>
		<category><![CDATA[CXCL1]]></category>
		<category><![CDATA[CXCR2 inhibitor]]></category>
		<category><![CDATA[ERBB2 mutations]]></category>
		<category><![CDATA[Glutamine Metabolism]]></category>
		<category><![CDATA[Leptomeningeal metastasis]]></category>
		<category><![CDATA[MSK-IMPACT]]></category>
		<category><![CDATA[ornithine]]></category>
		<category><![CDATA[spatial metabolomics]]></category>
		<category><![CDATA[trastuzumab deruxtecan]]></category>
		<category><![CDATA[triple-negative breast cancer]]></category>
		<category><![CDATA[tumor-associated macrophages]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=411764</guid>

					<description><![CDATA[New MSK studies reveal that immune cells secretly feed triple-negative breast cancer, a CXCR2 blocker sensitizes leptomeningeal metastases to radiation, ERBB2 mutations predict enhanced benefit from trastuzumab deruxtecan, tumor DNA testing extends survival in biliary tract cancers, and an AI system tracks embryonic development with high accuracy.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">411764</post-id>	</item>
	</channel>
</rss>
